Pharmaceuticals company Indoco Remedies announced Q1FY26 results Revenues of Indoco Remedies are at Rs 3,838 million, as against Rs 3,411 million, in previous quarter, registering 12.5% revenue growth. EBIDTA for the quarter is at Rs 148 million, compared to Rs 35 million in the previous quarter. Aditi Panandikar, Managing Director, Indoco Remedies, said: “Our 12.5% revenue growth this quarter over last quarter reflects the resilience of our teams, operational excellence and robust strategy. We are confident of sustaining this momentum and making a turnaround going ahead.” Result PDF